Researchers sought to determine whether combining enasidenib with venetoclax would be effective in patients with IDH2-mutated ...

The industry regulator has sanctioned three broker-dealers in the Cetera network for weak controls around low-priced securities and customer reporting.

Blood Cancer United®, formerly The Leukemia & Lymphoma Society, announced today that the first patient has received treatment ...

In this article, we examine why Canada has become a strategic launchpad for FinTech and crypto founders, and how executive teams can leverage AML Incubator to ...

The global anti-money laundering (AML) system market size was US$ 2.5 billion in 2021. The global anti-money laundering (AML) system market is forecast to grow to US$ 7.5 billion by 2030 by growing at ...

Liberian President Joseph N. Boakai has formally requested the Liberian Senate to amend the third Mineral Development Agreement (MDA) between the Government of Liberia and ArcelorMittal Liberia ...

Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN ...

The objectives of this guideline are to assist principals to develop and implement effective risk-based AML/CFT/CPF ...

The DOJ and FinCEN reached resolutions with Paxful, a US-based virtual currency trading platform, over Bank Secrecy Act and AML ...

The combination therapy, referred to as DAGO+m, yielded a 91% overall response rate and a promising 2-year overall survival ...

In this retrospective study, researchers stratified pediatric AML patients by risk and aimed to determine whether some could receive fewer chemotherapy cycles without affecting relapse and survival ...

Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.